blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3687570

EP3687570 - COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  31.03.2023
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  03.07.2020
FormerThe international publication has been made
Status updated on  06.04.2019
Formerunknown
Status updated on  12.10.2018
Most recent event   Tooltip14.12.2023New entry: Decision on request for further processing 
Applicant(s)For all designated states
Pfizer Inc.
66 Hudson Boulevard East
New York, NY 10001-2192 / US
[2023/14]
Former [2020/32]For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
Inventor(s)01 / ANDERSON, Annaliesa Sybil
49 Hillcrest Drive
Upper Saddle River, New Jersey 07458 / US
02 / DONALD, Robert G.K.
129 Kenneth Terrace
South Orange, New Jersey 07079 / US
03 / FLINT, Michael James
220 Spring Street
Decatur, Georgia 30030 / US
04 / JANSEN, Kathrin Ute
160 East 65th Street
New York, New York 10065 / US
05 / KITCHIN, Nicholas Randolph Everard
c/o Ramsgate Road
Sandwich Kent CT13 9NJ / GB
06 / MORAN, Justin Keith
26 Wheeler Place
West Nyack, New York 10994 / US
07 / PEDNEAULT, Louise
530 East 72nd Street
New York, New York 10021 / US
08 / PRIDE, Michael W.
80 Bay Street Landing
Unit 8A
Staten Island, New York 10301 / US
09 / RUPPEN, Mark Edward
6 Lea Court
Garnerville, New York 10923 / US
10 / WEBBER, Christopher Frederick
c/o Ramsgate Road
Sandwich Kent CT13 9NJ / GB
 [2020/32]
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2020/32]
Application number, filing date18779805.314.09.2018
[2020/32]
WO2018IB57076
Priority number, dateUS201762565096P28.09.2017         Original published format: US 201762565096 P
US201762576603P24.10.2017         Original published format: US 201762576603 P
US201762577661P26.10.2017         Original published format: US 201762577661 P
US201862720617P21.08.2018         Original published format: US 201862720617 P
[2020/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019064115
Date:04.04.2019
Language:EN
[2019/14]
Type: A1 Application with search report 
No.:EP3687570
Date:05.08.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 04.04.2019 takes the place of the publication of the European patent application.
[2020/32]
Search report(s)International search report - published on:EP04.04.2019
ClassificationIPC:A61K39/08, C07K16/12, C07K14/33, A61K39/00
[2020/32]
CPC:
A61K39/08 (EP,IL,KR,US); A61K9/19 (US); A61P31/04 (KR);
C07K14/33 (EP,IL,KR); C07K16/1282 (EP,IL,KR); A61K2039/545 (EP,IL,KR,US);
C07K2317/76 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/32]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR AUSLÖSUNG EINER IMMUNREAKTION GEGEN CLOSTRIDIUM DIFFICILE[2020/32]
English:COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE[2020/32]
French:COMPOSITIONS ET PROCÉDÉS DE GÉNÉRATION D'UNE RÉPONSE IMMUNITAIRE À CLOSTRIDIUM DIFFICILE[2020/32]
Entry into regional phase28.04.2020National basic fee paid 
28.04.2020Designation fee(s) paid 
28.04.2020Examination fee paid 
Examination procedure26.03.2020Amendment by applicant (claims and/or description)
28.04.2020Examination requested  [2020/32]
28.04.2020Date on which the examining division has become responsible
04.04.2023Despatch of a communication from the examining division (Time limit: M06)
08.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
04.12.2023Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
04.12.2023Request for further processing filed
04.12.2023Full payment received (date of receipt of payment)
Request granted
13.12.2023Decision despatched
Fees paidRenewal fee
30.09.2020Renewal fee patent year 03
30.09.2021Renewal fee patent year 04
30.09.2022Renewal fee patent year 05
02.10.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9920304  (ORAVAX INC [US]);
 [A]EP1568378  (ACAMBIS INC [US]);
 [A]US2012269841  (SIDHU MANINDER K [US], et al);
 [A]WO2014060898  (PFIZER [US]);
 [I]WO2014201346  (SANOFI PASTEUR INC [US]);
by applicantGB2220211
 WO9840100
 WO0062800
 WO2010067262
 WO2012143902
 WO2014060898
 US9187536
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.